The genetic history of Scandinavia from the Roman Iron Age to the present

The authors acknowledge support from the National Genomics Infrastructure in Stockholm funded by Science for Life Laboratory, the Knut and Alice Wallenberg Foundation and the Swedish Research Council, and SNIC/Uppsala Multidisciplinary Center for Advanced Computational Science for assistance with massively parallel sequencing and access to the UPPMAX computational infrastructure. We used resources from projects SNIC 2022/23-132, SNIC 2022/22-117, SNIC 2022/23-163, SNIC 2022/22-299, and SNIC 2021-2-17. This research was supported by the Swedish Research Council project ID 2019-00849_VR and ATLAS (Riksbankens Jubileumsfond). Part of the modern dataset was supported by a research grant from Science Foundation Ireland (SFI), grant number 16/RC/3948, and co-funded under the European Regional Development Fund and by FutureNeuro industry partners.Peer reviewedPublisher PD

Initial Data and a Clinical Diagnosis Transition for the Aiginition Longitudinal Biomarker Investigation of Neurodegeneration (ALBION) Study

Background and Objectives: This article presents data from the ongoing Aiginition Longitudinal Biomarker Investigation of Neurodegeneration study (ALBION) regarding baseline clinical characterizations and CSF biomarker profiles, as well as preliminary longitudinal data on clinical progression. Materials and Methods: As of March 2022, 138 participants who either were cognitively normal (CN, n = 99) or had a diagnosis of mild cognitive impairment (MCI, n = 39) had been recruited at the specialist cognitive disorders outpatient clinic at Aiginition Hospital. Clinical characteristics at baseline were provided. These patients were followed annually to determine progression from CN to MCI or even dementia. CSF biomarker data (amyloid β1-42, phosphorylated tau at threonine 181, and total tau) collected using automated Elecsys® assays (Roche Diagnostics) were available for 74 patients. These patients were further sorted based on the AT(N) classification model, as determined by CSF Aβ42 (A), CSF pTau (T), and CSF tTau (N). Results: Of the 49 CN patients with CSF biomarker data, 21 (43%) were classified as exhibiting “Alzheimer’s pathologic change” (A+Τ– (Ν)−) and 6 (12%) as having “Alzheimer’s disease” (A+T–(N)+, A+T+(N)–, or A+T+(N)+). Of the 25 MCI patients, 8 (32%) displayed “Alzheimer’s pathologic change”, and 6 (24%) had “Alzheimer’s disease”. A total of 66 individuals had a mean follow-up of 2.1 years (SD = 0.9, min = 0.8, max = 3.9), and 15 of those individuals (22%) showed a clinical progression (defined as a worsening clinical classification, i.e., from CN to MCI or dementia or from MCI to dementia). Overall, participants with the “AD continuum” AT(N) biomarker profile (i.e., A+T–(N)–, A+T–(N)+, A+T+(N)–, and A+T+(N)+) were more likely to clinically progress (p = 0.04). Conclusions: A CSF “AD continuum” AT(N) biomarker profile is associated with an increased risk of future clinical decline in CN or MCI subjects

Scientific knowledge gaps on the biology of non-fish marine species across European Seas

Available information and potential data gaps for non-fish marine organisms (cnidarians, crustaceans, echinoderms, molluscs, sponges, mammals, reptiles, and seabirds) covered by the global database SeaLifeBase were reviewed for eight marine ecosystems (Adriatic Sea, Aegean Sea, Baltic Sea, Bay of Biscay/Celtic Sea/Iberian Coast, Black Sea, North Sea, western Mediterranean Sea, Levantine Sea) across European Seas. The review of the SeaLifeBase dataset, which is based on published literature, analyzed information coverage for eight biological characteristics (diet, fecundity, maturity, length-weight relationships, spawning, growth, lifespan, and natural mortality). These characteristics are required for the development of ecosystem and ecological models to evaluate the status of marine resources and related fisheries. Our analyses revealed that information regarding these biological characteristics in the literature was far from complete across all studied areas. The level of available information was nonetheless reasonably good for sea turtles and moderate for marine mammals in some areas (Baltic Sea, Bay of Biscay/Celtic Sea/Iberian Coast, Black Sea, North Sea and western Mediterranean Sea). Further, seven of the areas have well-studied species in terms of information coverage for biological characteristics of some commercial species whereas threatened species are generally not well studied. Across areas, the most well-studied species are the cephalopod common cuttlefish (Sepia officinalis) and the crustacean Norway lobster (Nephrops norvegicus). Overall, the information gap is narrowest for length-weight relationships followed by growth and maturity, and widest for fecundity and natural mortality. Based on these insights, we provide recommendations to prioritize species with insufficient or missing biological data that are common across the studied marine ecosystems and to address data deficiencies